Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Morrell

Showing results (251-260 of 278) with videos related to

Pageof 28
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 10, 2019
2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLTGeorg Hansmann, Martin Koestenberger, Tero-Pekka Alastalo, et al.
The Lancet. Respiratory Medicine|January 23, 2016
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysisJonathan D W Evans, Barbara Girerd, David Montani, et al.
Annals of the American Thoracic Society|March 18, 2021
Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover TrialsLuke S G E Howard, Jianguo He, Geoffrey M J Watson, et al.
Human Mutation|January 24, 2006
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertensionRajiv D Machado, Micheala A Aldred, Victoria James, et al.
Nature Communications|November 16, 2019
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertensionNadine D Arnold, Josephine A Pickworth, Laura E West, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2018
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary HypertensionIvana Nikolic, Lai-Ming Yung, Peiran Yang, et al.
The European Respiratory Journal|January 19, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertensionMichael Newnham, Kieron South, Marta Bleda, et al.
Circulation Research|March 11, 2021
MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular DiseaseJoão P Monteiro, Julie Rodor, Axelle Caudrillier, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Pageof 28

Showing results (251-260 of 278) with videos related to

Sort By:
Pageof 28
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 10, 2019
2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLTGeorg Hansmann, Martin Koestenberger, Tero-Pekka Alastalo, et al.
The Lancet. Respiratory Medicine|January 23, 2016
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysisJonathan D W Evans, Barbara Girerd, David Montani, et al.
Annals of the American Thoracic Society|March 18, 2021
Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover TrialsLuke S G E Howard, Jianguo He, Geoffrey M J Watson, et al.
Human Mutation|January 24, 2006
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertensionRajiv D Machado, Micheala A Aldred, Victoria James, et al.
Nature Communications|November 16, 2019
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertensionNadine D Arnold, Josephine A Pickworth, Laura E West, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2018
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary HypertensionIvana Nikolic, Lai-Ming Yung, Peiran Yang, et al.
The European Respiratory Journal|January 19, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertensionMichael Newnham, Kieron South, Marta Bleda, et al.
Circulation Research|March 11, 2021
MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular DiseaseJoão P Monteiro, Julie Rodor, Axelle Caudrillier, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Pageof 28